BioCentury | Dec 15, 2014
Finance

Avanir Chronicles

Avanir Chronicles Avanir chroniclesThe $17 takeout price Otsuka Pharmaceutical Co. Ltd. will pay for Avanir Pharmaceuticals Inc. (NASDAQ:AVNR) is only a 13% premium to the neurology play's close the day before the $3.5 billion deal...
BC Week In Review | Apr 15, 2013
Clinical News

Lidakol 10 percent n-docosanol data

LDAKA released additional results from a trial in 10 HIV-1 infected patients with KS (see BioCentury March 24, 1997). All 10 patients exhibited decreased lesion size after 3 months, and of 2 biopsies performed 1...
BC Week In Review | Apr 15, 2013
Company News

Lidak management update

Lidak Pharmaceuticals (LDAKA), La Jolla, Calif.   Business: Infectious diseases, Autoimmune/Inflammation, Cancer   Hired: Jeffery Weinress as VP and CFO, formerly EVP and CFO at Omega Environmental Inc.  ...
BC Week In Review | Nov 16, 1998
Company News

Lidak, Livingston Healthcare Services Inc. sales and marketing update

Livingston will distribute LDAKA's docosanol cream to treat oral-facial herpes infections. The cream is under FDA review. Lidak Pharmaceuticals (LDAKA), San Diego, Calif.   Livingston Healthcare Services Inc., Newark, Del.   Business: Infectious diseases  ...
BC Week In Review | Nov 9, 1998
Company News

Lidak cancer, enabling technology, infectious diseases news

LDAKA filed suit in the California Superior Court for the County of San Diego against its former CEO, David Katz, alleging a plan by him to gain control of the company, failure to protect LDAKA's...
BC Week In Review | Oct 12, 1998
Company News

Lidak cancer, enabling technology, infectious diseases news

LDAKA will change its name to Avanir Pharmaceuticals subject to approval by a majority of the company's shareholders. Avanir reserved the ticker symbol AVNR on NASDAQ. Lidak Pharmaceuticals (LDAKA), San Diego, Calif.   Business: Cancer,...
BC Week In Review | Sep 28, 1998
Company News

Lidak management update

Lidak Pharmaceuticals (LDAKA), San Diego, Calif.   Business: Infectious diseases, Autoimmune/Inflammation   Hired: J. David Hansen as VP of sales and marketing, formerly senior director for strategic sales systems at Dura Pharmaceuticals Inc.  ...
BC Week In Review | Aug 17, 1998
Company News

Lidak, Medical Biology Institute cancer, infectious diseases, enabling technology news

The parties settled an April suit brought by LDAKA against Medical Biology, and a countersuit brought by Medical Biology against LDAKA, in San Diego County Superior Court. The suit sought to determine licensing rights between...
BC Week In Review | Jul 6, 1998
Company News

Lidak board of directors update

Lidak Pharmaceuticals (LDAKA), La Jolla, Calif.   Business: Infectious diseases   Appointed: George Rutland, chairman, CEO and a director of Tiapan Corp., as chairman; Edward Hennessey, retired chairman and CEO of Allied-Signal Inc.; Dennis Carlo,...
BC Week In Review | Mar 9, 1998
Company News

Lidak, HealthMed Inc. deal

HealthMed terminated discussions to provide LDAKA with $80-$130 million in loan financing (see BioCentury, Jan. 19 and March 2). Lidak Pharmaceuticals (LDAKA), La Jolla, Calif.   HealthMed Inc. , Los Angeles, Calif.   Business: Infectious diseases...
Items per page:
1 - 10 of 67
BioCentury | Dec 15, 2014
Finance

Avanir Chronicles

Avanir Chronicles Avanir chroniclesThe $17 takeout price Otsuka Pharmaceutical Co. Ltd. will pay for Avanir Pharmaceuticals Inc. (NASDAQ:AVNR) is only a 13% premium to the neurology play's close the day before the $3.5 billion deal...
BC Week In Review | Apr 15, 2013
Clinical News

Lidakol 10 percent n-docosanol data

LDAKA released additional results from a trial in 10 HIV-1 infected patients with KS (see BioCentury March 24, 1997). All 10 patients exhibited decreased lesion size after 3 months, and of 2 biopsies performed 1...
BC Week In Review | Apr 15, 2013
Company News

Lidak management update

Lidak Pharmaceuticals (LDAKA), La Jolla, Calif.   Business: Infectious diseases, Autoimmune/Inflammation, Cancer   Hired: Jeffery Weinress as VP and CFO, formerly EVP and CFO at Omega Environmental Inc.  ...
BC Week In Review | Nov 16, 1998
Company News

Lidak, Livingston Healthcare Services Inc. sales and marketing update

Livingston will distribute LDAKA's docosanol cream to treat oral-facial herpes infections. The cream is under FDA review. Lidak Pharmaceuticals (LDAKA), San Diego, Calif.   Livingston Healthcare Services Inc., Newark, Del.   Business: Infectious diseases  ...
BC Week In Review | Nov 9, 1998
Company News

Lidak cancer, enabling technology, infectious diseases news

LDAKA filed suit in the California Superior Court for the County of San Diego against its former CEO, David Katz, alleging a plan by him to gain control of the company, failure to protect LDAKA's...
BC Week In Review | Oct 12, 1998
Company News

Lidak cancer, enabling technology, infectious diseases news

LDAKA will change its name to Avanir Pharmaceuticals subject to approval by a majority of the company's shareholders. Avanir reserved the ticker symbol AVNR on NASDAQ. Lidak Pharmaceuticals (LDAKA), San Diego, Calif.   Business: Cancer,...
BC Week In Review | Sep 28, 1998
Company News

Lidak management update

Lidak Pharmaceuticals (LDAKA), San Diego, Calif.   Business: Infectious diseases, Autoimmune/Inflammation   Hired: J. David Hansen as VP of sales and marketing, formerly senior director for strategic sales systems at Dura Pharmaceuticals Inc.  ...
BC Week In Review | Aug 17, 1998
Company News

Lidak, Medical Biology Institute cancer, infectious diseases, enabling technology news

The parties settled an April suit brought by LDAKA against Medical Biology, and a countersuit brought by Medical Biology against LDAKA, in San Diego County Superior Court. The suit sought to determine licensing rights between...
BC Week In Review | Jul 6, 1998
Company News

Lidak board of directors update

Lidak Pharmaceuticals (LDAKA), La Jolla, Calif.   Business: Infectious diseases   Appointed: George Rutland, chairman, CEO and a director of Tiapan Corp., as chairman; Edward Hennessey, retired chairman and CEO of Allied-Signal Inc.; Dennis Carlo,...
BC Week In Review | Mar 9, 1998
Company News

Lidak, HealthMed Inc. deal

HealthMed terminated discussions to provide LDAKA with $80-$130 million in loan financing (see BioCentury, Jan. 19 and March 2). Lidak Pharmaceuticals (LDAKA), La Jolla, Calif.   HealthMed Inc. , Los Angeles, Calif.   Business: Infectious diseases...
Items per page:
1 - 10 of 67